Trademark: 88886717
Word
MYOGENDYS
Status
Dead
Status Code
606
Status Date
Monday, April 11, 2022
Serial Number
88886717
Mark Type
4000
Filing Date
Friday, April 24, 2020
Published for Opposition
Tuesday, July 14, 2020
Abandoned Date
Monday, April 11, 2022

Trademark Owner History
Sarepta Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Trademark Events
Apr 11, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 11, 2022
Abandonment - No Use Statement Filed
Aug 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 26, 2021
Sou Extension 2 Granted
Aug 26, 2021
Sou Extension 2 Filed
Aug 26, 2021
Teas Extension Received
Feb 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 19, 2021
Sou Extension 1 Granted
Feb 19, 2021
Sou Extension 1 Filed
Feb 19, 2021
Teas Extension Received
Sep 8, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 14, 2020
Published For Opposition
Jun 24, 2020
Notification Of Notice Of Publication E-Mailed
Jun 5, 2020
Approved For Pub - Principal Register
Jun 3, 2020
Assigned To Examiner
May 6, 2020
New Application Office Supplied Data Entered In Tram
Apr 28, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24